There is one diagnostic currently on the market fo
Post# of 30013
![](/assets/46931549/no_avatar_available_thumb.jpg)
It does $2 billion a year.
Sensitivity is the ability of the test to identify correctly those who have
a disease.
Specificity is the ability of the test to identify correctly those who do
not have a disease.
CA125 has the following:
Sensitivity - 50%
Specificity - 60%
OvaDx has the following:
Sensitivity - 93%
Specificity - 99%
The plan is to license or sell it to a large diagnostic company. AVDX has already been in talks with Roche Diagnostics.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)